COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 1974: Articles 19731-19740  | Next

Comparative analysis of the first wave of the COVID-19 pandemic in South Korea, Italy, Spain, France, Germany, the United Kingdom, the USA and the New-York state
Alvarez, L.
10.1101/2020.11.20.20235689 — Posted: 2020-11-23
Outbreaks of publications about emerging infectious diseases: the case of SARS-CoV-2 and Zika virus
Ipekci, M. A., Buitrago-Garcia, D., Meili, K. W., Krauer, F., Prajapati, N., Thapa, S., Wildisen, L., Chaveron, L. A., Baumann, L., Shah, S., Whiteley, T., Solis-Garcia, G., Tsotra, F., Zhelyazkov, I., Imeri, H., Low, N., Counotte, M. J.
10.1101/2020.11.20.20235242 — Posted: 2020-11-23
High infectiousness immediately before COVID-19 symptom onset highlights the importance of contact tracing
Hart, W. S., Maini, P. K., Thompson, R. N.
10.1101/2020.11.20.20235754 — Posted: 2020-11-23
Modeling the spread of Covid-19 under active management
Cherednik, I.
10.1101/2020.11.20.20235903 — Posted: 2020-11-23
Actionable druggable genome-wide Mendelian randomization identifies repurposingopportunities for COVID-19
Gaziano, L., Giambartolomei, C., Pereira, A. C., Gaulton, A., Posner, D. C., Swanson, S. A., Ho, Y. L., Iyengar, S. K., Kosik, N. M., Vujkovic, M., Gagnon, D. R., Bento, A. P., Beltrao, P., Barrio Hernandez, I., Ronnblom, L., Hagberg, N., Lundtoft, C., Langenberg, C., Pietzner, M., Valentine, D., Allara, E., Surendran, P., Burgess, S., Zhao, J. H., Peters, J. E., Prins, B. P., Danesh, J., Devineni, P., Shi, Y., Lynch, K. E., DuVall, S. L., Garcon, H., Thomann, L., Zhou, J. J., Gorman, B. R., Huffman, J. E., O'Donnell, C. J., Tsao, P. S., Beckham, J. C., Pyarajan, S., Muralidhar, S., Huang, G. D., Ramoni, R., Hung, A. M., Chang, K.-M., Sun, Y. V., Joseph, J., Leach, A. R., Edwards, T. L., Cho, K., Gaziano, J. M., Butterworth, A. S., Casas, J. P.
10.1101/2020.11.19.20234120 — Posted: 2020-11-23
Is Standard Personal Protective Equipment Effective Enough To Prevent COVID-19 Transmission During Aerosol Generating Dental, Oral and Maxillofacial Procedures ? A Systematic Review
Al-Moraissi, E. A., abood, M., Alasseri, N., Gunther, F., Neff, A.
10.1101/2020.11.20.20235333 — Posted: 2020-11-23
On-site rapid molecular testing, mobile sampling teams and eHealth to support primary care physicians during the COVID-19 pandemic
Cheung, N. N., Boers, S. A., Kiani deh Kiani, S., Jansen, R. W., Mook-Kanamori, D. O., Janssens, L., Feltkamp, M. C. W., Kroes, A. C. M., Mourik, B. C.
10.1101/2020.11.20.20234898 — Posted: 2020-11-23
How strong is the epidemiological evidence to support any potential protective role for vitamin D levels on COVID-19 infections and mortality? - A time-series analysis of European Populations
Singh, S.
10.1101/2020.11.20.20235705 — Posted: 2020-11-23
Single cell profiling of COVID-19 patients: an international data resource from multiple tissues
Ballestar, E., Farber, D. L., Glover, S., Horwitz, B., Meyer, K., Nikolic, M., Ordovas-Montanes, J., Sims, P. A., Shalek, A. K., Vandamme, N., Vandekerckhove, L., Vento-Tormo, R., Villani, A. C., Chan Zuckerberg Initiative Single-Cell COVID-19 Consortia
10.1101/2020.11.20.20227355 — Posted: 2020-11-23
Coagulation factors and COVID-19 severity: Mendelian randomization analyses and supporting evidence
Zhou, Y., Liu, Z., Yang, H., Wang, J., Li, M. J.
10.1101/2020.11.20.20235440 — Posted: 2020-11-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).